Morbidity and Mortality Weekly Report: Recommendations and Reports, April 4, 1997 / Vol. 46 / No. RR-8

Details

• Alternative Title:
  Prevention of Pneumococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Breiman, Robert F. ; Butler, Jay C. ; Nuorti, J. Pekka ; Breiman, Robert F. ; Butler, Jay C. ; Nuorti, J. Pekka
• Corporate Authors:
  Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases. ; Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Infectious Diseases (U.S.). Division of Bacterial and Mycotic Diseases.
• Description:
  " This report updates the last recommendations by the Advisory Committee on Immunization Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989;38:64-8,73-6). ACIP recommends that the vaccine be used more extensively and administered to all persons in the following groups: a) persons aged greater than or equal to 65 years, b) immunocompetent persons aged greater than or equal to 2 years who are at increased risk for illness and death associated with pneumococcal disease because of chronic illness, c) persons aged greater than or equal to 2 years with functional or anatomic asplenia, d) persons aged greater than or equal to 2 years living in environments in which the risk for disease is high, and e) immunocompromised persons aged greater than or equal to 2 years who are at high risk for infection. This report contains updated information regarding a) antimicrobial resistance among pneumococci, b) vaccine effectiveness and cost-effectiveness, c) indications for vaccination, d) guidelines for revaccination, e) strategies for improving delivery of vaccine, and f) development of pneumococcal conjugate vaccine." - p. 1
  
  Includes bibliographical references (p. 19-24).
  
  
• Subjects:
  Pneumococcal Infections Pneumococcal Vaccines Pneumonia, Pneumococcal Vaccination Vaccines, Conjugate
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1997; v. 46, no. 8 ; Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 1997; v. 46, no. 8
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)   ; Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)  
• ISSN:
  1057-5987 (print) ; 1545-8601 (digital)
• Pubmed ID:
  9132580
• Document Type:
  Journal Issue
• Genre:
  Practice Guideline ; Practice Guideline
• Place as Subject:
  United States
• Location:
  North America ; North America
• Pages in Document:
  32 pdf pages
• Volume:
  46
• Issue:
  8
• Collection(s):
  Guidelines and Recommendations Advisory Committee on Immunization Practices (ACIP) Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:3a5b1594d19077fd39a99e0a321e9a5c3d91d4db952981bcd206e79bbad2278d4215458a781774ecd569c5641fcd531b18c807b9edde961267b3fb7cd2435b67
• Download URL:
  https://stacks.cdc.gov/view/cdc/5708/cdc_5708_DS1.pdf
• File Type:
  [PDF - 287.30 KB ]